BOCCACCIO, Carla
 Distribuzione geografica
Continente #
NA - Nord America 3.782
EU - Europa 2.419
AS - Asia 1.541
OC - Oceania 35
AF - Africa 17
SA - Sud America 17
Continente sconosciuto - Info sul continente non disponibili 2
Totale 7.813
Nazione #
US - Stati Uniti d'America 3.701
CN - Cina 1.022
IT - Italia 663
DE - Germania 259
IE - Irlanda 253
SE - Svezia 234
GB - Regno Unito 172
FR - Francia 171
FI - Finlandia 152
UA - Ucraina 151
JP - Giappone 132
KR - Corea 119
CA - Canada 64
IN - India 58
PL - Polonia 57
NL - Olanda 56
ES - Italia 47
BE - Belgio 46
CH - Svizzera 40
HK - Hong Kong 36
AU - Australia 31
VN - Vietnam 30
TW - Taiwan 29
SG - Singapore 24
AT - Austria 18
RU - Federazione Russa 17
DK - Danimarca 13
IR - Iran 13
TH - Thailandia 12
TR - Turchia 12
IL - Israele 11
MX - Messico 11
RO - Romania 11
BR - Brasile 10
NO - Norvegia 10
GR - Grecia 8
ID - Indonesia 8
MY - Malesia 8
CZ - Repubblica Ceca 6
PT - Portogallo 6
RS - Serbia 6
DZ - Algeria 5
HU - Ungheria 5
IQ - Iraq 5
PE - Perù 5
JO - Giordania 4
NZ - Nuova Zelanda 4
PK - Pakistan 4
SN - Senegal 4
EG - Egitto 3
LU - Lussemburgo 3
UZ - Uzbekistan 3
AE - Emirati Arabi Uniti 2
AL - Albania 2
BA - Bosnia-Erzegovina 2
DM - Dominica 2
EE - Estonia 2
EU - Europa 2
GL - Groenlandia 2
LK - Sri Lanka 2
MA - Marocco 2
PH - Filippine 2
SI - Slovenia 2
AR - Argentina 1
BY - Bielorussia 1
CO - Colombia 1
CR - Costa Rica 1
GE - Georgia 1
HR - Croazia 1
KZ - Kazakistan 1
LT - Lituania 1
LV - Lettonia 1
LY - Libia 1
ME - Montenegro 1
MT - Malta 1
NG - Nigeria 1
NP - Nepal 1
PR - Porto Rico 1
QA - Qatar 1
SA - Arabia Saudita 1
SK - Slovacchia (Repubblica Slovacca) 1
UG - Uganda 1
Totale 7.813
Città #
Chandler 542
Ann Arbor 391
Beijing 296
Dublin 243
Fairfield 186
Ashburn 173
Houston 149
Shanghai 129
Dearborn 108
Redwood City 106
Torino 100
Wilmington 95
Jacksonville 90
Princeton 87
Woodbridge 86
Turin 81
Villeurbanne 80
Seattle 79
Medford 77
Milan 67
Cambridge 58
New York 58
Nyköping 57
Guangzhou 56
Warsaw 51
Tokyo 44
Boston 36
Pisa 36
Wuhan 33
Hangzhou 32
Nanjing 29
Rome 27
Fremont 25
Boardman 24
Chengdu 23
Brussels 22
Dong Ket 22
Hefei 21
Verona 20
San Diego 19
Vienna 18
Helsinki 17
London 17
Paris 17
Changsha 16
Shenyang 16
Luni 15
Ottawa 15
Zhengzhou 15
Chicago 14
Taipei 14
Toronto 14
Falls Church 13
Genoa 13
Jinan 13
Lappeenranta 13
Xian 13
Cossato 12
Los Angeles 12
Seoul 12
Utrecht 12
Zurich 12
Amsterdam 11
Madrid 10
Munich 10
Norwalk 10
Shenzhen 10
Washington 10
Hebei 9
Osaka 9
Carrara 8
Duncan 8
Fuzhou 8
Lachine 8
Melbourne 8
Singapore 8
Stockholm 8
Bern 7
Edinburgh 7
Kunming 7
Nashville 7
Padova 7
Phoenix 7
Rochester 7
San Jose 7
Tianjin 7
Barcelona 6
Belgrade 6
Bethesda 6
Central 6
Central District 6
Copenhagen 6
Florence 6
Frankfurt Am Main 6
Frankfurt am Main 6
Manchester 6
Nanchang 6
Nürnberg 6
Siena 6
Silver Spring 6
Totale 4.453
Nome #
Known and novel roles of the MET oncogene in cancer: A coherent approach to targeted therapy 1.411
Induction of MET by Ionizing Radiation and Its Role in Radioresistance and Invasive Growth of Cancer 714
Selective analysis of cancer-cell intrinsic transcriptional traits defines novel clinically relevant subtypes of colorectal cancer 318
Met signaling regulates growth, repopulating potential and basal cell-fate commitment of mammary luminal progenitors: implications for basal-like breast cancer. 309
Colorectal cancer residual disease at maximal response to EGFR blockade displays a druggable Paneth cell–like phenotype 216
Genetic Evolution of Glioblastoma Stem-Like Cells From Primary to Recurrent Tumor 214
The MET oncogene is a functional marker of a glioblastoma stem cell subtype. 193
MET signaling in colon cancer stem-like cells blunts the therapeutic response to EGFR inhibitors. 162
A molecularly annotated model of patient-derived colon cancer stem-like cells to assess genetic and non-genetic mechanisms of resistance to anti-EGFR therapy 162
TNF-α promotes invasive growth through the MET signaling pathway. 150
Wild-type p53 controls cell motility and invasion by dual regulation of MET expression. 149
MET-Mediated Resistance to EGFR Inhibitors: An Old Liaison Rooted in Colorectal Cancer Stem Cells. 141
MET inhibition overcomes radiation resistance of glioblastoma stem-like cells 128
A differentiation switch for genetically modified hepatocytes. 124
Cancer of unknown primary stem-like cells model multi-organ metastasis and unveil liability to MEK inhibition 117
The MET Oncogene in Glioblastoma Stem Cells: Implications as a Diagnostic Marker and a Therapeutic Target. 114
Induction of epithelial tubules by growth factor HGF depends on the STAT pathway. 113
WHEN REGULATION FAILS: HOW CANCER ARISES 108
Cancer of Unknown Primary (CUP): genetic evidence for a novel nosological entity? A case report 107
Cancer and blood coagulation 95
A simplified integrated molecular and immunohistochemistry-based algorithm allows high accuracy prediction of glioblastoma transcriptional subtypes 89
HGF/scatter factor selectively promotes cell invasion by increasing integrin avidity 84
A functional role for hemostasis in early cancer development 82
Apoptosis enhancement by the HIV-1 Nef protein. 81
I recettori per i fattori di crescita 80
Exploring the interplay between MET and Tumor Necrosis Factor alpha 78
Ets up-regulates MET transcription 77
The MET oncogene drives a genetic programme linking cancer to haemostasis 76
ERBB3 overexpression due to miR-205 inactivation confers sensitivity to FGF, metabolic activation, and liability to ERBB3 targeting in glioblastoma 76
Ionizing radiation fosters cancer invasion through transcriptional up-regulation of the MET oncogene 72
Tumor cell-derived Timp-1 is necessary for maintaining metastasis-promoting Met-signaling via inhibition of Adam-10. 72
A disintegrin and metalloproteinase-10 (ADAM-10) mediates DN30 antibody-induced shedding of the met surface receptor 72
Activation of the MET receptor attenuates doxorubicin-induced cardiotoxicity in vivo and in vitro 72
Efficient gene delivery and targeted expression to hepatocytes in vivo by improved lentiviral vectors. 71
“Metastatic Cancer of Unknown Primary” or “Primary Metastatic Cancer”? 66
I RECETTORI PER I FATTORI DI CRESCITA 65
Derivation and charaterization of cancer initialling cells representative of metastatic colorectal cancer genetic heterogeneity 65
Hepatocyte growth factor is a regulator of monocyte-macrophage function 64
I FATTORI DI CRESCITA CONTROLLANO LA PROLIFERAZIONE CELLULARE 63
Fibroblast nemosis arrests growth and induces differentiation of human leukemia cells 63
Colorectal cancer stem cells, MET and metastasis 63
Invasive growth: a MET-driven genetic programme for cancer and stem cells 63
I RECETTORI PER I FATTORI DI CRESCITA 61
Hepatocyte growth factor (HGF) receptor expression is inducible and is part of the delayed-early response to HGF. 60
The HIV-1 nef protein interferes with phosphatidylinositol 3-kinase activation 1. 57
Profiling YB-1 target genes uncovers a new mechanism for MET receptor regulation in normal and malignant human mammary cells 56
Ligand-independent tyrosine phosphorylation of the receptor encoded by the c-neu oncogene. 56
Cerebrospinal fluid tumor DNA for liquid biopsy in glioma patients’ management: Close to the clinic? 56
Plasminogen-related growth factor and semaphorin receptors: a gene superfamily controlling invasive growth. 54
Scatter factors and invasive growth. 53
L'oncogene MET e la cescita invasiva delle cellule staminali del cancro 52
ERBB3 as a therapeutic target in glioblastoma: overexpression can make the difference 52
The HGF receptor family: unconventional signal transducers for invasive cell growth. 51
The MET oncogene drives a genetic programme for stem and cancer cells 51
The MET Oncogene as a Therapeutical Target in Cancer Invasive Growth 51
Genetic link between cancer and thrombosis 50
GROWTH FACTORS AND CELL SIGNALLING 49
Interactions between growth factor receptors and adhesion molecules: breaking the rules. 48
The long-lasting protective effect of HGF in cardiomyoblasts exposed to doxorubicin requires a positive feed-forward loop mediated by ERK1,2-TIMP1-STAT3 47
Growth Factor Receptors 46
QUANDO FALLISCE LA REGOLAZIONE: L'INSORGENZA DEL CANCRO 42
Scatter factor-dependent branching morphogenesis: structural and histological features 42
I recettori per i fattori di crescita 42
L'oncogene MET regola programmi cellulari che legano il cancro all'emostasi 41
Oncogenes, cancer, and haemostasis 40
Scatter factors in tumor progression 39
Hepatocyte Growth Factor: A marker and a player in disseminated intravascular coagulation 37
MET, a driver of invasive growth and cancer clonal evolution under therapeutic pressure. 35
Coexisting cancer stem cells with heterogeneous gene amplifications, transcriptional profiles, and malignancy are isolated from single glioblastomas 29
MET∆14 promotes a ligand-dependent, AKT-driven invasive growth 19
The PSI Domain of the MET Oncogene Encodes a Functional Disulfide Isomerase Essential for the Maturation of the Receptor Precursor 16
Real-world histopathological approach to malignancy of undefined primary origin (MUO) to diagnose cancers of unknown primary (CUPs) 15
Mutated axon guidance gene PLXNB2 sustains growth and invasiveness of stem cells isolated from cancers of unknown primary 12
Liquid biopsy of cerebrospinal fluid enables selective profiling of glioma molecular subtypes at first clinical presentation 10
An mTOR feedback loop mediates the 'flare' ('rebound') response to MET tyrosine kinase inhibition 6
Protocol for in vitro establishment of heterogeneous stem-like cultures derived from whole human glioblastoma tumors 4
Correction to: Real-world histopathological approach to malignancy of undefined primary origin (MUO) to diagnose cancers of unknown primary (CUPs) 3
MicroRNA 483-3p overexpression unleashes invasive growth of metastatic colorectal cancer via NDRG1 downregulation and ensuing activation of the ERBB3/AKT axis 2
Totale 8.023
Categoria #
all - tutte 20.075
article - articoli 0
book - libri 0
conference - conferenze 1.306
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 21.381


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019187 0 0 0 0 0 0 0 0 0 0 128 59
2019/20201.054 52 32 55 91 68 172 158 86 105 117 72 46
2020/20211.156 85 67 97 79 111 66 115 55 132 105 102 142
2021/20221.405 100 111 100 103 102 71 103 92 81 69 251 222
2022/20231.804 176 121 80 161 153 341 156 151 194 46 140 85
2023/2024940 171 144 60 85 77 161 61 74 18 78 11 0
Totale 8.023